Search Results - "ELFSSON, B"

Stability of 5-aminolevulinic acid in aqueous solution by Elfsson, B, Wallin, I, Eksborg, S, Rudaeus, K, Ros, A.M, Ehrsson, H

“…The chemical stability of 5-aminolevulinic acid (ALA) was studied in aqueous solution as a function of concentration, pH, temperature and in the presence of…”
Get full text

Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial by Lenander, Cecilia, Elfsson, Birgitta, Danielsson, Birgitta, Midlöv, Patrik, Hasselström, Jan

“…Abstract Objective. To determine whether a pharmacist-led medications review in primary care reduces the number of drugs and the number of drug-related…”
Get full text

Determination of the acid dissociation constant for cis-diammineaquachloroplatinum(II) ion. A hydrolysis product of cisplatin by Andersson, A, Hedenmalm, H, Elfsson, B, Ehrsson, H

“…The biological activity of the anticancer drug cisplatin is supposed to be mediated by its reactive hydrolysis product cis-diammineaquachloroplatinum(II) ion…”
Get more information

Pharmacokinetics and distribution of liposomal busulfan in the rat : a new formulation for intravenous administration by HASSAN, M, HASSAN, Z, NILSSON, C, MOHAMED ABDEL REHIM, KUMLIEN, S, ELFSSON, B, KALLBERG, N

“…The plasma pharmacokinetics and tissue distribution of busulfan (Bu) were investigated after intravenous injection of free Bu (D-Bu) and freshly prepared…”
Get full text

Doxorubicin- and daunorubicin-induced energy deprivation and nucleotide degradation in isolated cardiomyocytes by Vidal, Ricardo F., Eksborg, Staffan, Sundberg, Monica, Carlberg, Magdalena, Elfsson, Birgitta, Andersson, Bo S.

“…Cytotoxic mechanisms of the antitumor agents daunorubicin and doxorubicin were elucidated in isolated cardiomyocytes from adult rats. Incubation with…”
Get full text

Epirubicin as a single agent therapy for the treatment of breast cancer--a pharmacokinetic and clinical study by Eksborg, S, Hardell, L, Bengtsson, N O, Sjödin, M, Elfsson, B

“…Sixty women with breast cancer (mean age: 61 years; range 36-78 years) were treated with Epirubicin (4'epi-Doxorubicin), 60 mg m-2, as single drug therapy. The…”
Get more information